#AlembicPharma reports its Q4 results:
▶️Net Profit Up 29% At ₹202 Cr Vs ₹157 Cr (YoY)
▶️Revenue Up 4.4% At ₹1,848 Cr Vs ₹1,770 Cr (YoY)
▶️EBITDA Down 16.2% At ₹228 Cr Vs ₹272 Cr (YoY)
▶️Margin At 12.3% Vs 15.4% (YoY)
▶️Net Profit Up 29% At ₹202 Cr Vs ₹157 Cr (YoY)
▶️Revenue Up 4.4% At ₹1,848 Cr Vs ₹1,770 Cr (YoY)
▶️EBITDA Down 16.2% At ₹228 Cr Vs ₹272 Cr (YoY)
▶️Margin At 12.3% Vs 15.4% (YoY)
#StockInNews | Bharat Forge arm to set up manufacturing unit with an investment ₹1,500 cr in Andhra Pradesh
#StockInNews | Coal India: CIL may sell stake in MCL via OFS as part of IPO